Chinese Journal of New Drugs 2012 Issue 20 Effect of uric acid on lipid metabolism of mouse and quail

Effect of uric acid on lipid metabolism of mouse and quail
WU Zhen-jue;ZHANG Yu-bin

..............page:2420-2423

Comparison of guidelines from ICH/FDA/EMA/WHO on non-clinical studies of fixed combinations of medical products
GUANG Hong-mei;HU Xiao-min

..............page:2356-2358,2403

Reseach advances of pegylated human typeⅠarginase
ZHAO Jing1;2;YANG Zhong-fan2;WU Yan-zhuo2;XU Ming-bo2;WANG Min1

..............page:2376-2379

Application of dexmedetomidine in pediatric anesthesiology
CHEN Hua1;2;LI Min1

..............page:2404-2407

2011 nian yao pin zhu ce shen pi nian du bao gao

..............page:2341-2345

bian zhe tui jian

..............page:2335

shi jie xin yao zhi chuang

..............page:2339-2340

Policy selection of regulatory data protection under the background of drug innovation strategy in China
CHEN Jing;CHEN Chang-xiong;SHI Lu-wen

..............page:2349-2352

Individualized dosing regimen for myocardial infarction patients in practice of clinical pharmacists
HAN Qiang

..............page:2447-2449

shou jie quan qiu kang ti gao feng lun tan zuo wu xi yao ming kang de yan fa sheng chan ji di tou yun qing dian yuan man wan cheng

..............page:2338

Validation of test method for microbial limits of paroxetine hydrochloride film-coated tablets
SU Zhi-yang

..............page:2434-2436

U.S. drug shortage and the holistic countermeasures taken by FDA
YAO Li-xin1;Garth Boehm1;ZHENG Qiang1;2

..............page:2359-2367

Retrospective analysis of adverse drug reactions in 1 585 cases in Yishui County
ZHU Lin-lin1;ZHANG Wei-hua2;YU Feng-hua1

..............page:2454-2460

Preparation of novel metformin hydrochloride osmotic pump controlled release tablets and study on pharmacokinetics in Beagle dogs
YIN Jian1;3;FENG Yan2;LU Jun2;LIU Zhi-dong1;3;SHI Jian-xin2

..............page:2429-2433

Guideline on the requirements for quality documentation concerning biological investigational medicinal products in clinical trials
CAO Yu-ran;SHI Yao-guo;ZHANG Jing

..............page:2408-2410,2440

Recent advances in the development of factor Xa
JIANG Kai;ZHANG Hui-bin;ZHOU Jin-pei;XING Jun-hao

..............page:2380-2387

Research progress of thermo-sensitive intelligent materials and related formualtions
HU Dai1;2;FU Xu-dong1

..............page:2398-2403

The effect of JinghuaWeikang capsule and PPI trilogy on the treatment of Helicobacter pylori infection in 80 cases
ZHU Xiu-fang;DUAN Zhi-ying;NIU Wei-wei;WANG Jing;FAN Hong-yun;HUO Xiao-hui

..............page:2417-2419

Hydrophilic modified zein improves the bioavailability of nifedipine
LIU Li1;2;ZHANG Cai-yun1;2;LU Chuan-hua1;2;LIN Teng1;2;XIE Jun-jun1;2

..............page:2441-2446

Application of GnRH antagonists in gonadal hormone dependent diseases
LI Hong-xing;LIU Li-jun;JING Yuan-xue;LIU Meng-yi;XUE Shi-long

..............page:2394-2397

Synthesis of clevidipine butyrate
CHEN Ji1;ZHANG Ai-ming2;ZHU Xue-yan1;YUAN Zhe-dong1

..............page:2368-2370

mei guo fda pi zhun po ni song xin ji xing yong yu zhi liao lei feng shi guan jie yan

..............page:2375

Research progress of G-protein coupled receptor 119 agonists
JIANG Kun1;JIANG Cheng2;WANG Ju-bo2;SONG Li-jun2;LI Zhi-yu2

..............page:2388-2393

Recovery and its influencing factors of rhynchophylline microdialysis probe
MA Bo1;2;SUN Gui-bo1;LI Ming1;3;SUN Xiao-bo1

..............page:2371-2375

Separation and purification of L-serine in enzymatic production
WEI Ping-he1;PENG Jia-ping1;ZHOU Xi-liang1;WANG Ping2

..............page:2424-2428,2446

Linagliptin,a new antihyperglycemic agent for type 2 diabetes
SHI Wei-feng;LI Xiao-yu;LIU Gao-lin

..............page:2346-2348,2367

Clinical pharmacists’ intervention using prescription automatic screening system in therapeutic drug monitoring
HU Ting-ting;YONG Xiao-lan;SHI Hui-qing;DONG Zhao-hui

..............page:2450-2453,2460

Clinical observation of pemetrexed alone in the treatment of advanced recurrent lung adenocarcinoma
ZHANG Ping;WU Xiao-nan;NIE Xin;ZHANG Zi-jin;LI Lin;CHENG Gang

..............page:2411-2413

kyorin zhi yao gong si mei ri 1 ci pian ji pentasa~ zuo zai ri ben huo pi yong yu huan jie qi kui yang xing jie chang yan

..............page:2419

Comparison of dissolution profiles of different cefaclor products for suspension using similarity factor f₂
CHENG Yi1;QIU Jian-she2;HU Rui-biao1;CHEN Wei-hong1

..............page:2437-2440

Impact of medical data protection on drug expenditure and accessibility in China
WU Suo-wei1;HAN Sheng1;CHEN Jing1;2;SHI Lu-wen1;2

..............page:2353-2355

Clinical observation of effect of transdermal fentanyl in eldly lung cancer patients with cancer pain
XIAN Hai-bing;FENG Wei-neng;ZHANG Hua;LIANG Jian-miao;DENG Yan-ming

..............page:2414-2416